COLL - Company ID 0001267565
COLLEGIUM PHARMACEUTICAL, INC (COLL) reported net income of $63.00M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | $63.00M | -8.7% |
| FY 2024 | $69.00M | +43.8% |
| FY 2023 | $48.00M | +292.0% |
| FY 2022 | -$25.00M | -134.7% |
| FY 2021 | $72.00M | +169.1% |
| FY 2020 | $26.75M | +217.7% |
| FY 2019 | -$22.72M | +41.9% |
| FY 2018 | -$39.13M | +47.7% |
| FY 2017 |
COLLEGIUM PHARMACEUTICAL, INC (COLL) reported net income of $63.00M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2013 and fiscal 2025, COLLEGIUM PHARMACEUTICAL, INC's net income grew from -$16.20M to $63.00M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| -$74.86M |
| +20.5% |
| FY 2016 | -$94.18M | -245.5% |
| FY 2015 | -$27.25M | -52.1% |
| FY 2014 | -$17.92M | -10.6% |
| FY 2013 | -$16.20M | - |